Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
about
Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults
description
scientific article published on 01 October 2019
@en
name
Public Health Impact and Cost- ...... ter Vaccine in Canadian Adults
@en
type
label
Public Health Impact and Cost- ...... ter Vaccine in Canadian Adults
@en
prefLabel
Public Health Impact and Cost- ...... ter Vaccine in Canadian Adults
@en
P2093
P1476
Public Health Impact and Cost- ...... ter Vaccine in Canadian Adults
@en
P2093
Desiree Van Oorschot
Desmond Curran
Hyosung Jung
Michael L Ganz
Michael Stokes
Robyn Widenmaier
P304
P356
10.1007/S40258-019-00491-6
P577
2019-10-01T00:00:00Z